Clinical Trials Sponsored by New River Pharmaceuticals

Total 138 results

New River Pharmaceuticals

Completed

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
New River Pharmaceuticals

Completed

NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

Attention Deficit Disorder With Hyperactivity
New River Pharmaceuticals

Completed

Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity Disorders

United States
New River Pharmaceuticals

Completed

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
New River Pharmaceuticals
Shire

Completed

An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity Disorders

United States
New River Pharmaceuticals
Shire

Completed

Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD

Attention Deficit Hyperactivity Disorder
Yangtze River Pharmaceutical Group Co., Ltd.

Completed

A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol

Erectile Dysfunction

China
New Haven Pharmaceuticals, Inc.

Completed

Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease (DURATION)

Cardiovascular Disease

United States
National Liver Institute, Egypt
Pharco Pharmaceuticals

Unknown

Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients

Pharmacological Action

Egypt
Harbin Medical University
Yangtze River Pharmaceutical Group Co., Ltd.

Recruiting

Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction (COOPERATION)

Percutaneous Coronary Intervention | ST-segment Elevation Myocardial Infarction (STEMI) | Cardioprotection

China
National Liver Institute, Egypt
Future pharmaceutical industries

Recruiting

Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management (NILE)

Helicobacter Pylori

Egypt
Hospital for Special Surgery, New York
Northwell Health; The New York Community Trust; East River Medical Imaging

Recruiting

Effects of Bisphosphonates on OI-Related Hearing Loss

Osteogenesis Imperfecta

United States
Qiang Fu
Yangtze River Pharmaceutical Group Co., Ltd.

Not yet recruiting

Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules (CRF)

Cancer-related Fatigue
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NSCLC | Non-small Cell Lung Cancer | PD-1

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL

RR DLBCL; PD-1; CD20
Shandong New Time Pharmaceutical Co., LTD

Recruiting

A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients

Recruiting

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule

A Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520

Advanced Solid Tumor，Recurrent Solid Tumor，Lymphoma，Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma

China
Shandong New Time Pharmaceutical Co., LTD

Recruiting

Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors

Solid Tumors

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Osteoporosis

China
Shandong New Time Pharmaceutical Co., LTD

Not yet recruiting

Study of F527 in Patients With Relapsed or Refractory Lymphoma

Relapsed/Refractory Lymphoma

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

Efficacy and Safety

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma

Locally Advanced or Metastatic Urothelial Cell Carcinoma
Shandong New Time Pharmaceutical Co., LTD

Unknown

The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).

Peripheral T Cell Lymphoma
Shandong New Time Pharmaceutical Co., LTD

Recruiting

Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma

Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma

China
Shandong New Time Pharmaceutical Co., LTD

Completed

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Cervical Cancer

China
Shandong New Time Pharmaceutical Co., LTD

Completed

Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg

Bioequivalence

China
Shandong New Time Pharmaceutical Co., LTD

Unknown

A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)

Primary Central Nervous System Lymphoma | Secondary Central Nervous System Lymphoma
Yangtze River Pharmaceutical Group Co., Ltd.
Nanfang Hospital, Southern Medical University

Recruiting

Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery

Postoperative Pain | Rehabilitation

China
New York State Psychiatric Institute
Novartis Pharmaceuticals

Completed

Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo

Healthy

United States
Southern Europe New Drug Organization
Novartis Pharmaceuticals

Completed

LBH Phase II in Small Cell Lung Cancer (SCLC)

Small Cell Lung Carcinoma

Germany, Italy
Boston University Charles River Campus
National Institute on Aging (NIA); University of New England

Completed

Amped-PD: Amplifying Physical Activity Through Music in Parkinson Disease (Amped-PD)

Parkinson Disease

United States
Mirum Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc.; Childhood Liver Disease Research and Education...

Completed

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome (IMAGINE-II)

Alagille Syndrome

United States, Canada
Mirum Pharmaceuticals, Inc.
Childhood Liver Disease Research and Education Network

Completed

Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome (ITCH)

Alagille Syndrome

United States, Canada
Hospital for Special Surgery, New York
Novartis Pharmaceuticals

Completed

Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis

Systemic Sclerosis

United States
Reproductive Medicine Associates of New Jersey
Ferring Pharmaceuticals

Completed

Single Embryo Transfer of a Euploid Embryo Versus Double Embryo Transfer

Infertility

United States
Reproductive Medicine Associates of New Jersey
Ferring Pharmaceuticals

Completed

Next Generation Sequencing Screening for Embryonic Ploidy Status (nexgen)

Infertility

United States
Drug Induced Liver Disease Study Group
Beijing Union Pharmaceutical Factory

Recruiting

The Multi-Center, Randomized, Double-blind, Positive Controlled Clinical Trial of Bicyclol in the Treatment of Acute DILI

Drug-Induced Acute Liver Injury

China
Drug Induced Liver Disease Study Group
Beijing Union Pharmaceutical Factory

Completed

The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI

Drug-Induced Acute Liver Injury

China
White River Junction Veterans Affairs Medical Center
Dartmouth College; US Endoscopy; Aries Pharmaceuticals, Inc.

Recruiting

Cold Snare Endoscopic Mucosal Resection Trial (LPS-II)

Recurrence | Colonic Polyp | Colonoscopy | Complication

United States
University of New Mexico
La Jolla Pharmaceutical Company

Recruiting

Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock (DARK-Sepsis)

Septic Shock | Vasodilatory Shock

United States
Psoriasis Treatment Center of Central New Jersey
Regeneron Pharmaceuticals

Recruiting

Dupixent and Narrowband UVB for Atopic Dermatitis

Atopic Dermatitis

United States
Hospital for Special Surgery, New York
Auxilium Pharmaceuticals, Inc.

Completed

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Dupuytren's Disease

United States
Vitreous -Retina- Macula Consultants of New York
Regeneron Pharmaceuticals

Withdrawn

Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment

Fibrovascular Pigment Epithelial Detachment

United States
Vitreous -Retina- Macula Consultants of New York
Regeneron Pharmaceuticals

No longer available

Use of Eylea for the Treatment of an Optic Nerve Hemangioma

Retinal Hemangioma

United States
First Affiliated Hospital Xi'an Jiaotong University
Fudan University; Yangtze River Pharmaceutical Group Co., Ltd.

Unknown

A Low-dose Radiation and Contrast Agent Exposure Protocol for Coronary CTA in Diabetic Patients

Coronary Artery Disease

China
Community Research Initiative of New England
Tibotec Pharmaceutical Limited

Completed

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r (LARD)

HIV Infections

United States
Psoriasis Treatment Center of Central New Jersey
Taro Pharmaceuticals USA

Completed

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

Psoriasis

United States
Psoriasis Treatment Center of Central New Jersey
Taro Pharmaceuticals USA

Completed

Topical Psoriasis Study for Patients Receiving Biologic Therapy

Psoriasis

Clinical Trials Sponsored by New River Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations